Navigation Links
MedCath Corporation to Hold Conference Call on Fourth Quarter Results
Date:10/31/2008

CHARLOTTE, N.C., Oct. 31 /PRNewswire-FirstCall/ -- MedCath Corporation (Nasdaq: MDTH) will host a conference call Friday, Nov. 14, at 9 a.m. Eastern Time to discuss results from its fourth quarter ended Sept. 30, 2008. The company will issue a press release announcing those results prior to the earnings call.

What: Fourth Quarter Earnings Conference Call

When: 9:00 a.m. ET, Friday, Nov. 14, 2008

How: Dial-in conference call

(877) 697-5351 (domestic callers), (706) 634-0602

(international callers)

Conference ID: 71798429

Live web cast at http://www.medcath.com

Contacts: O. Edwin French, President & CEO

Jeff Hinton, CFO

The conference call will be archived and accessible by dialing (800) 642-1687 (domestic callers) or (706) 645-9291 (international callers). The archived conference ID is 71798429. The call will be accessible until 11:59 p.m. ET on Nov. 21, 2008. It also will be available on the company's web site (http://www.medcath.com) on or immediately following Nov. 14 for 30 days.

MedCath Corporation, headquartered in Charlotte, N.C., is a healthcare provider focused on high acuity services with the diagnosis and treatment of cardiovascular disease being a primary service offering. MedCath owns an interest in and operates nine hospitals with a total of 616 licensed beds, located in Arizona, Arkansas, California, Louisiana, New Mexico, South Dakota, and Texas. MedCath is in the process of developing its tenth hospital, which is anticipated to open in fall 2009, in Kingman, Ariz. In additi
'/>"/>

SOURCE MedCath Corporation
Copyright©2008 PR Newswire.
All rights reserved

Page: 1 2

Related medicine news :

1. MedCath Corporation Reports Fourth Quarter Earnings and Outlook for Fiscal 2008
2. MedCath Corporation to Present at the BMO Capital Markets 2007 Focus on Healthcare Conference
3. MedCath Corporation to Present at the 26th Annual JPMorgan Healthcare Conference
4. MedCath Corporation to Hold Conference Call on First Quarter Results
5. MedCath Corporation Reports First Quarter Earnings
6. MedCath Plans 60-bed Expansion at TexSAn Heart Hospital
7. MedCath Announces Venture With Two New Jersey Hospitals
8. MedCath Corporation to Present at the Raymond James 29th Annual Institutional Investors Conference
9. MedCath Corporation to Present at the Citi 2008 Small and Mid-Cap Conference
10. MedCath Enters Definitive Agreement to Sell Dayton Heart Hospital to Good Samaritan Hospital-Dayton
11. MedCath Announces Acquisition of Ownership in Arizona Cath Lab
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:9/4/2015)... ... September 04, 2015 , ... Bio-Logic Aqua® Research, ... devices, announced its only mission and research focus: Water Life Science®. In the ... body water evaporation is becoming dangerously accelerated. As a result of the global ...
(Date:9/4/2015)... ... September 04, 2015 , ... The conference program for the ... October 9-10, 2015 at the Diplomat Resort & Spa has been announced and ... researchers at the top of their field and will be presenting sessions such ...
(Date:9/4/2015)... Seattle, Washington (PRWEB) , ... September 04, 2015 ... ... the design and development of its first neighborhood created specifically for adults with ... located in the Phoenix Metro area and feature 30 cottage or “pocket” homes. ...
(Date:9/4/2015)... , ... September 04, 2015 , ... ... Benker Residence in South Glastonbury, Connecticut, has been selected for the Residential Award ... significant energy efficiency and resiliency measures. Chosen from a highly competitive field of ...
(Date:9/4/2015)... ... ... Overseer at The House of Yahweh, has written an open letter to Pope Francis that ... States. , Yisrayl lays out what he says is the true meaning of the Pope’s ... the meaning of his own name and describes what bible prophecy says about his own ...
Breaking Medicine News(10 mins):Health News:Bio-Logic Aqua® Research Announces Water Life Science and Body Water Evaporation as Research Focus and Mission 2Health News:Bio-Logic Aqua® Research Announces Water Life Science and Body Water Evaporation as Research Focus and Mission 3Health News:Integrative Healthcare Symposium Focus On: The Microbiome Conference Program Announced 2Health News:Cottage Home Communities for Disabled Adults to Create First Viable Permanent Housing Option 2Health News:Cottage Home Communities for Disabled Adults to Create First Viable Permanent Housing Option 3Health News:Cottage Home Communities for Disabled Adults to Create First Viable Permanent Housing Option 4Health News:South Glastonbury Home Selected for Award by Connecticut Green Building Council 2Health News:Yisrayl Hawkins Writes Open Letter to Pope Francis In Light of Approaching U.S. Visit 2
... an estimated 10 to 13 percent of the American diet. ... in 2007 was $70.5 billion, with estimates for 2008 rising ... into the United States of imported food and food-related products ... which include ports, border crossings, and postal facilities. ...
... Remedy for Long Islanders, NEW YORK, March 19 ... conducted this past month reveals that Long,Islanders are taking ... of,prescription drugs. One in five (21%) residents delay filling ... as food and,heat. In addition, 12% lack any prescription ...
... Ranks CDH Among Health Care Leaders, WINFIELD, ... Central DuPage Hospital in Winfield, Ill., has been ... U.S. by Thomson, a national,healthcare information company. This ... DuPage Hospital is the first DuPage County hospital ...
... Quarter Common Stock Dividend of $0.25-, CHICAGO, March ... today announced that its Board of Directors has approved ... up to $150,million in the aggregate of the Company,s ... said, "As we,discussed on our recent earnings call, we ...
... 90% of drugs entering,clinical development fail to get ... adverse side effects not detected in animal tests. ... using stem cell,technologies, potentially saving drug developers millions, ... Markets for,Transplantation, Cord Blood Banking and Drug Development, ...
... with pregnancy responds to energy restoration, MANCHESTER, Conn., ... today,s USA Today, board-certified cardiologist Stephen T. Sinatra,M.D., F.A.C.C., ... and often,misunderstood form of heart disease. Responding to a ... developed peripartum cardiomyopathy, an,uncommon and mystifying type of heart ...
Cached Medicine News:Health News:Long Islanders Take Unhealthy Measures to Afford Their Prescriptions 2Health News:Central DuPage Hospital One of the Top 100 Hospitals in the U.S. for Second Year 2Health News:Brookdale Board of Directors Authorizes $150 Million Share Repurchase Program 2Health News:Brookdale Board of Directors Authorizes $150 Million Share Repurchase Program 3Health News:Brookdale Board of Directors Authorizes $150 Million Share Repurchase Program 4Health News:Brookdale Board of Directors Authorizes $150 Million Share Repurchase Program 5Health News:Stem Cell Technology Offers Promise of Huge Savings for Drug Developers 2Health News:Metabolic Cardiologist Offers New Hope for Women With Heart Disease 2
(Date:9/4/2015)... -- Research and Markets ( http://www.researchandmarkets.com/research/gbd3bt/stability_testing ... Testing of Pharmaceuticals (London, UK - December 2-3, 2015)" ... this comprehensive two day seminar delegates will: ... are suitable for global arketing - Be able ... samples and facilities - Know how to save ...
(Date:9/3/2015)... MUMBAI, India , Sept. 3, 2015  Cipla, ... to meet the everyday needs of all patients, today ... into definitive agreements to acquire two US-based companies, InvaGen ... subject to certain closing conditions, is valued at $550 ... combined revenue from these transactions is over $200 million ...
(Date:9/3/2015)... With a population of more than 1 ... also its single largest potential market for goods and ... all major world economies in the average rate of ... health expenditures. As an in vitro diagnostics (IVD) market, ... United States, western European countries, and Japan. China represents ...
Breaking Medicine Technology:Stability Testing of Pharmaceuticals: 2 Day Seminar - London, UK - December 2-3, 2015 2Cipla to acquire 100% of generic businesses in US for $550M 2Cipla to acquire 100% of generic businesses in US for $550M 3Cipla to acquire 100% of generic businesses in US for $550M 4Cipla to acquire 100% of generic businesses in US for $550M 5IVD in China 2IVD in China 3IVD in China 4IVD in China 5IVD in China 6IVD in China 7IVD in China 8IVD in China 9IVD in China 10IVD in China 11IVD in China 12IVD in China 13
... SILVER SPRING, Md., May 6, 2011 The U.S. Food ... allow a new group of patients at risk of stroke ... RX Acculink carotid stent. (Logo: http://photos.prnewswire.com/prnh/20090824/FDALOGO ) ... neck bring blood to the brain. The blood flow in ...
... BEACH, Calif., May 6, 2011 Yesterday, the ... Novartis drug Afinitor® (everolimus) for the treatment of ... less than five percent of all pancreatic cancer ... aggressive than the more common form of pancreatic ...
Cached Medicine Technology:FDA Expands Approved Use For Carotid Stent 2FDA Expands Approved Use For Carotid Stent 3FDA Approves Novartis Drug Afinitor to Treat Pancreatic Neuroendocrine Tumors 2
... E+ is a precision rotary ... advance with manual cutting. The ... easy to operate. Coarse Advance ... option of manually advancing the ...
The Shandon Cryotome E Cryostat model features an automated, precise electronic specimen advance system....
... Netmon remote monitoring service allows the ... and monitored from any location via ... service enhances preventive maintenance capabilities. ... the unit (with your permission) from ...
Shandon HistoWave is the answer to rapid tissue processing. It reduces time for fixation, tissue processing, decalification, immunochemistry and special stains....
Medicine Products: